Ken Harris: Why AI and automation are CGT’s next inflection point
Jan 27, 2026 - 01:03:25
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Carl Schoellhammer: viability is the crucial third pillar in CGT
In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to discuss the importance of considering viability alongside safety and efficacy in cell and gene the...
About This Episode
Carl Schoellhammer: viability is the crucial third pillar in CGT is an episode from Ori Spotlight by Ori Biotech. In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to disc...
Podcast
This episode belongs to Ori Spotlight.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jun 25, 2024, 00:48:55 long, audio available.
Related Episodes
Continue listening to more episodes from Ori Spotlight.
Joe DePinto: Why advanced therapies need a new delivery model
Jan 13, 2026 - 01:04:41
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
Dec 16, 2025 - 00:55:35
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
Sep 2, 2025 - 00:40:41
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
Aug 12, 2025 - 01:00:07
Henrik Andersen: How smart planning helps CGT scale further, faster
Jul 15, 2025 - 00:54:20
Questions About This Episode
What is Carl Schoellhammer: viability is the crucial third pillar in CGT about?
In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to discuss the importance of considering viability alongside safety and efficacy in cell and gene therapies (CGTs). Schoellhammer highlights the need for scalable and decentralized manufacturing approaches to ensure the commercial viability of these advanced therapies, as well as the challenges of maintaining consistent quality in personalized medicines, and the role of enabling technologies in addressing these hurdles. Learn more about Carl:
Where can I listen to Carl Schoellhammer: viability is the crucial third pillar in CGT?
You can listen to Carl Schoellhammer: viability is the crucial third pillar in CGT online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Carl Schoellhammer: viability is the crucial third pillar in CGT from?
Carl Schoellhammer: viability is the crucial third pillar in CGT is an episode from Ori Spotlight by Ori Biotech.
How long is this episode?
This episode is 00:48:55 long.
When was this episode published?
This episode was published on Jun 25, 2024.
Can I save Carl Schoellhammer: viability is the crucial third pillar in CGT for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Ori Spotlight?
Yes. This page shows related episodes from Ori Spotlight when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Carl Schoellhammer: viability is the crucial third pillar in CGT?
You can listen to Carl Schoellhammer: viability is the crucial third pillar in CGT on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Carl Schoellhammer: viability is the crucial third pillar in CGT is from Ori Spotlight by Ori Biotech.
What are the episode details?
Published Jun 25, 2024 and 00:48:55 long